{
    "nct_id": "NCT06896162",
    "official_title": "PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival",
    "inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "• Subjects with an active concurrent malignancy.",
    "miscellaneous_criteria": "In order to participate in this study a subject must meet all of the eligibility criteria outlined below.\n\nInclusion Criteria\n\n* Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information.\n* Subjects are willing and able to comply with study procedures based on the judgment of the investigator.\n* Age ≥ 18 years at the time of consent.\n* ECOG or Karnofsky Performance Status of 0-2.\n* Documented Stage IV solid tumor malignancy: NSCLC, CRC, Breast or Bladder Cancer\n* The treating provider deems Next Generation Sequencing (NGS) testing appropriate and plans to consider results in either first- or second-line therapy in the metastatic setting\n* A genomic tumor test has not been ordered or has been ordered but not resulted."
}